Chronic spontaneous urticaria (CSU), a skin condition marked by sudden eruptions.
FDA offers clarity on post-warning letter meetings in new draft guidance
FDA on Friday published draft guidance laying out its approach to post-warning letter meetings for generic drugmakers, including the criteria for granting the meetings and